Godrej Industries Ltd enters the Q1 FY27 results with a focus on navigating divergent performance across its diverse portfolio, from real estate and consumer goods to chemicals and agri-business. Investors will be closely watching for signs of margin stabilization in the chemicals segment and the impact of recent freight and packaging cost headwinds on its subsidiary operations.
| Results date | August 13, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Previous quarter revenue | Rs. 8,274 Cr |
| Previous quarter PAT | Rs. 444 Cr |
| Market cap | Rs. 42,463.44 Cr |
| CMP | Rs. 1,260.6 |
The Board of Directors is scheduled to meet on August 13, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026.
The company faces a mixed start to FY27, with Godrej Agrovet's oil palm segment showing a 29% YoY revenue surge in Q1, despite a 220 bps margin compression to 16.7% due to seasonal pricing formulas. The chemicals segment remains under pressure, with the Q4 FY26 PBIT margin of 3.6% highlighting the ongoing challenge of elevated feedstock costs and global demand headwinds. Meanwhile, finance costs remain a key monitorable following the 26% YoY increase in FY26 interest expenses and the recent issuance of Rs. 1,000 Cr in NCDs at 8.23% p.a. Management's commentary on the Iran-war-induced freight and packaging cost inflation will be critical, as will the seasonal performance of Godrej Properties relative to its record-breaking Q4 FY26 booking value.
Chemicals segment margin recovery: Monitoring the path to PBIT margin stabilization after the 46% YoY decline observed in Q4 FY26.
Godrej Agrovet performance vs FY27 guidance: Evaluating progress toward the early double-digit revenue growth target amid external cost pressures.
Interest expense and debt trajectory: Tracking the impact of rising debt levels on the group's bottom line.
Godrej Properties booking momentum: Assessing the seasonal Q1 performance against the record-setting FY26 pipeline.
In FY26, the chemicals segment achieved revenue of Rs. 4,135 Cr, marking a 22% YoY increase. However, PBIT contracted 15% YoY to Rs. 307 Cr, reflecting significant margin pressure.
Mr. Nadir Godrej will retire as Chairman & MD on August 13, 2026, and transition to Chairman Emeritus. Mr. Pirojsha Godrej will assume the role of Chairperson effective August 14, 2026.
Finance costs rose 26% YoY in FY26 to Rs. 2,470 Cr, driven by higher borrowings for subsidiary investments. The company recently issued Rs. 1,000 Cr in NCDs at 8.23% p.a. to support business operations and loan repayments.